Virucidal efficacy of guanidine-free inactivants and rapid test buffers against SARS-CoV-2

Virucidal efficacy of guanidine-free inactivants and rapid test buffers against SARS-CoV-2

Abstract A pathogen inactivation step during collection or processing of clinical samples has the potential to reduce infectious risks associated with diagnostic procedures. It is essential that these inactivation methods are demonstrated to be effective, particularly for non-traditional inactivatio...

Full description

Bibliographic Details
Main Authors: Katherine Davies, Ulrike Arnold, Hubert Buczkowski, Christopher Burton, Stephen R. Welch, Nicole Green, Rhea Strachan, Tracy Beetar-King, Peter Spencer, Nipunadi Hettiarachchi, Matthew J. Hannah, Matthew Jones, Patricia A. Cane, Christine B. Bruce, Neil Woodford, Allen D. G. Roberts, Marian J. Killip
Format: Article
Language:English
Published: Nature Portfolio 2021-12-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-02942-4

Internet

https://doi.org/10.1038/s41598-021-02942-4

Similar Items